Tower Research Capital (TRC)’s Proshares UltraPro NASDAQ Biotechnology UBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-5,075
| Closed | -$166K | – | 4423 |
|
|
2019
Q4 | $166K | Sell |
5,075
-8,839
| -64% | -$289K | 0.01% | 669 |
|
|
2019
Q3 | $263K | Sell |
13,914
-1,821
| -12% | -$34.4K | 0.02% | 869 |
|
|
2019
Q2 | $407K | Buy |
15,735
+13,275
| +540% | +$343K | 0.03% | 560 |
|
|
2019
Q1 | $72K | Sell |
2,460
-12,019
| -83% | -$352K | ﹤0.01% | 1586 |
|
|
2018
Q4 | $290K | Buy |
14,479
+7,293
| +101% | +$146K | 0.02% | 584 |
|
|
2018
Q3 | $318K | Sell |
7,186
-1,455
| -17% | -$64.4K | 0.02% | 732 |
|
|
2018
Q2 | $286K | Buy |
+8,641
| New | +$286K | 0.02% | 890 |
|
|
2018
Q1 | – | Sell |
-38,065
| Closed | -$1.28M | – | 4222 |
|
|
2017
Q4 | $1.28M | Buy |
+38,065
| New | +$1.28M | 0.17% | 136 |
|
|
2017
Q3 | – | Sell |
-4,112
| Closed | -$131K | – | 4440 |
|
|
2017
Q2 | $131K | Buy |
4,112
+1,686
| +69% | +$53.7K | 0.01% | 416 |
|
|
2017
Q1 | $67K | Sell |
2,426
-6,302
| -72% | -$174K | 0.01% | 617 |
|
|
2016
Q4 | $184K | Sell |
8,728
-4,905
| -36% | -$103K | 0.02% | 666 |
|
|
2016
Q3 | $396K | Sell |
13,633
-19,208
| -58% | -$558K | 0.04% | 220 |
|
|
2016
Q2 | $697K | Buy |
32,841
+31,884
| +3,332% | +$677K | 0.07% | 203 |
|
|
2016
Q1 | $23K | Sell |
957
-1,940
| -67% | -$46.6K | ﹤0.01% | 1258 |
|
|
2015
Q4 | $167K | Buy |
+2,897
| New | +$167K | 0.03% | 214 |
|
|
2015
Q3 | – | Sell |
-40
| Closed | -$4K | – | 5195 |
|
|
2015
Q2 | $4K | Buy |
+40
| New | +$4K | ﹤0.01% | 3443 |
|